שולי רווח נקי ממכירות: Know Labs Corp (KNW)

The strategic goal of Know Labs, Inc. (KNW) is to obtain FDA certification for its non-invasive glucose monitor to expand into the diabetes market. Effective sales margins illustrate progress toward this objective, where 0.00 shows the current volume of this metric. Barriers remain the need to establish pricing power in the biosensor sector and the maintenance of flawless production facilities for mass manufacturing.
Know Labs Corp (KNW) - פילוחי מדדים ודוחות פיננסיים

Know Labs, Inc. (KNW) focuses on the certification of non-invasive sensors and the protection of intellectual property. The sales margin reflects the share of net profit in revenue, demonstrating the efficiency of cost management. This ratio links operating expenses to the company's final financial result. Analyzing the sales margin profile on GURU.Markets allows investors to filter out inefficient assets. Investors should evaluate the dynamics of this indicator to confirm the viability of the business model.